Shandong Pharmaceutical Glass Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Packaging
  • ISIN: CNE000001BG9
CNY
18.29
-0.81 (-4.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,451.93
4,881.92
4,770.85
4,152.00
3,863.59
3,413.55
2,980.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,451.93
4,881.92
4,770.85
4,152.00
3,863.59
3,413.55
2,980.46
Raw Material Cost
3,071.39
3,334.74
3,374.15
3,120.00
2,768.90
2,313.20
1,920.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.60
3.23
0.23
2.55
3.12
3.58
0.83
Selling and Distribution Expenses
273.19
310.46
346.88
229.04
248.78
267.39
387.37
Other Expenses
14.65
12.91
13.77
11.54
11.80
11.98
11.53
Total Expenditure (Excl Depreciation)
3,494.68
3,777.53
3,858.98
3,466.97
3,138.82
2,703.96
2,423.78
Operating Profit (PBDIT) excl Other Income
957.2
1104.4
911.9
685
724.8000000000001
709.5999999999999
556.7
Other Income
48.16
65.94
65.56
61.98
7.75
-1.59
19.62
Operating Profit (PBDIT)
1,274.15
1,479.78
888.22
1,018.94
928.71
883.29
714.13
Interest
3.60
3.23
0.23
2.55
3.12
3.58
0.83
Exceptional Items
-44.65
19.40
22.83
-13.17
3.77
-8.32
1.84
Gross Profit (PBDT)
1,380.54
1,547.18
1,396.70
1,032.00
1,094.69
1,100.35
1,060.15
Depreciation
395.08
385.15
0.00
295.17
240.64
217.90
169.10
Profit Before Tax
830.83
1,110.81
910.82
708.05
688.72
653.48
546.04
Tax
141.20
167.81
135.02
89.76
97.63
89.04
87.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
689.63
942.99
775.80
618.29
591.09
564.44
458.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
689.63
942.99
775.80
618.29
591.09
564.44
458.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
689.63
942.99
775.80
618.29
591.09
564.44
458.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,294.64
8,007.77
0.00
6,961.68
4,670.30
4,255.89
3,867.78
Earnings per share (EPS)
1.04
1.42
1.17
1.03
0.99
0.95
0.77
Diluted Earnings per share
1.04
1.42
1.17
1.03
0.99
0.95
0.77
Operating Profit Margin (Excl OI)
18.66%
21.07%
17.24%
15.94%
17.61%
19.54%
17.63%
Gross Profit Margin
27.54%
30.64%
19.09%
24.16%
24.05%
25.53%
23.99%
PAT Margin
15.49%
19.32%
16.26%
14.89%
15.3%
16.54%
15.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -8.81% vs 2.33% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -26.87% vs 21.55% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -13.28% vs 71.85% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 12.50% vs 1,500.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Shandong Pharmaceutical Glass Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
4,451.93
0
4,451.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,451.93
0
4,451.93
Raw Material Cost
3,071.39
0
3,071.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.60
0
3.60
Selling and Distribution Expenses
273.19
0
273.19
Other Expenses
14.65
0.00
14.65
Total Expenditure (Excl Depreciation)
3,494.68
0
3,494.68
Operating Profit (PBDIT) excl Other Income
957.25
0.00
957.25
Other Income
48.16
0
48.16
Operating Profit (PBDIT)
1,274.15
0
1,274.15
Interest
3.60
0
3.60
Exceptional Items
-44.65
0
-44.65
Gross Profit (PBDT)
1,380.54
0
1,380.54
Depreciation
395.08
0
395.08
Profit Before Tax
830.83
0
830.83
Tax
141.20
0
141.20
Provisions and contingencies
0
0
0.00
Profit After Tax
689.63
0
689.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
689.63
0
689.63
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
689.63
0
689.63
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,294.64
0
8,294.64
Earnings per share (EPS)
1.04
0
1.04
Diluted Earnings per share
1.04
0
1.04
Operating Profit Margin (Excl OI)
18.66%
0%
0.00
18.66%
Gross Profit Margin
27.54%
0%
0.00
27.54%
PAT Margin
15.49%
0%
0.00
15.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 445.19 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -8.81% vs 2.33% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 68.96 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -26.87% vs 21.55% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 122.60 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -13.28% vs 71.85% in Dec 2024

Annual - Interest
Interest 0.36 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 12.50% vs 1,500.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.66%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024